SECOND AMENDMENT TO SENIOR CONVERTIBLE NOTE Purchase Agreement April 13, 2020Senior Convertible Note Purchase Agreement • April 14th, 2020 • Coherus BioSciences, Inc. • Biological products, (no disgnostic substances) • New York
This Amendment to Convertible Note Purchase Agreement (this “Amendment”) is entered into as of the date first written above by and among Coherus BioSciences, Inc., a Delaware corporation (the “Company”) and the undersigned holders (each a “Holder” and collectively, the “Holders”) that are parties to that certain Senior Convertible Note Purchase Agreement, dated as of February 29, 2016, by and among the Company and the holders named therein (as amended, the “Note Purchase Agreement”). Capitalized terms used herein but not otherwise defined shall have the meanings ascribed to them in the Note Purchase Agreement.
FIRST AMENDMENT TO CREDIT AGREEMENTCredit Agreement • April 14th, 2020 • Coherus BioSciences, Inc. • Biological products, (no disgnostic substances)
THIS FIRST AMENDMENT TO CREDIT AGREEMENT (this “Amendment”), dated as of April 13, 2020 (the “Amendment Effective Date”), is made among COHERUS BIOSCIENCES, INC., a Delaware corporation (the “Borrower”), HCR COLLATERAL MANAGEMENT, LLC, as administrative agent (in such capacity, “Administrative Agent”) and the Lenders signatory hereto representing the Required Lenders.
